Sökning: WFRF:(Kononen Juha) > Repeated centralize...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07260naa a2200745 4500 | |
001 | oai:DiVA.org:uu-446847 | |
003 | SwePub | |
008 | 210805s2021 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:154400671 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4468472 URI |
024 | 7 | a https://doi.org/10.1016/j.lanepe.2021.1000492 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1544006712 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Osterlund, Piau Karolinska Institutet,Tampere Univ Hosp, Dept Oncol, Teiskontie 35,POB 2000, Tampere 33520, Finland.;Univ Tampere, Tampere, Finland.;Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland.;Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Karolinska Univ Hosp, Stockholm, Sweden.4 aut |
245 | 1 0 | a Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO) :b A nationwide prospective intervention study |
264 | 1 | b Elsevier,c 2021 |
338 | a electronic2 rdacarrier | |
520 | a Background: Resection of colorectal cancer (CRC) metastases provides good survival but is probably underused in real-world practice. Methods: A prospective Finnish nationwide study enrolled treatable metastatic CRC patients. The intervention was the assessment of resectability upfront and twice during first-line therapy by the multidisciplinary team (MDT) at Helsinki tertiary referral centre. The primary outcome was resection rates and survival. Findings: In 2012-2018, 1086 patients were included. Median follow-up was 58 months. Multiple metastatic sites were present in 500 (46%) patients at baseline and in 820 (76%) during disease trajectory. In MDT assessments, 447 (41%) were classified as resectable, 310 (29%) upfront and 137 (18%) after conversion therapy. Sixhundred and ninety curative intent resections or local ablative therapies (LAT) were performed in 399 patients (89% of 447 resectable). Multiple metastasectomies for multisite or later developing metastases were performed in 148 (37%) patients. Overall, 414 liver, 112 lung, 57 peritoneal, and 107 other metastasectomies were performed. Median OS was 80.4 months in R0/1-resected (HR 0.15; CI95% 0.12-0.19), 39.1 months in R2-resected/LAT (0.39; 0.29-0.53) patients, and 20.8 months in patients treated with "systemic therapy alone" (reference), with 5-year OS rates of 66%, 40%, and 6%, respectively. Interpretation: Repeated centralized MDT assessment in real-world metastatic CRC patients generates high resectability (41%) and resection rates (37%) with impressive survival, even when multisite metastases are present or develop later. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Colorectal cancer | |
653 | a Metastatic | |
653 | a Multidisciplinary | |
653 | a Resection | |
653 | a Resectability | |
653 | a Multisite metastases | |
653 | a Conversion | |
700 | 1 | a Salminen, Tapiou Tampere Univ Hosp, Dept Oncol, Teiskontie 35,POB 2000, Tampere 33520, Finland.;Univ Tampere, Tampere, Finland.4 aut |
700 | 1 | a Soveri, Leena-Maijau Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland.;Hyvinkaa Hosp & Home Care, Dept Palliat Care, Hyvinkaa, Finland.4 aut |
700 | 1 | a Kallio, Raijau Oulu Univ Hosp, Dept Oncol, Oulu, Finland.;Univ Oulu, Oulu, Finland.4 aut |
700 | 1 | a Kellokumpu, Ilmou Cent Hosp Cent Finland, Dept Gastrointestinal Surg, Jyyaskyla, Finland.4 aut |
700 | 1 | a Lamminmäki, Annamarjau Kuopio Univ Hosp, Dept Oncol, Kuopio, Finland.;Univ Kuopio, Kuopio, Finland.4 aut |
700 | 1 | a Halonen, Päiviu Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland.4 aut |
700 | 1 | a Ristamäki, Raijau Turku Univ Hosp, Dept Oncol, Turku, Finland.;Univ Turku, Turku, Finland.4 aut |
700 | 1 | a Lantto, Eilau Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland.;Univ Helsinki, Helsinki, Finland.;Paijat Home Cent Hosp, Dept Radiol, Lahti, Finland.4 aut |
700 | 1 | a Uutela, Akiu Univ Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Dept Transplantat & Liver Surg, Helsinki, Finland.4 aut |
700 | 1 | a Österlund, Emeriku Uppsala universitet,Experimentell och klinisk onkologi,Univ Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Dept Transplantat & Liver Surg, Helsinki, Finland.;Akad Sjukhuset, Uppsala, Sweden.4 aut0 (Swepub:uu)emeos639 |
700 | 1 | a Ovissi, Aliu Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland.;Univ Helsinki, Helsinki, Finland.4 aut |
700 | 1 | a Nordin, Arnou Univ Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Dept Transplantat & Liver Surg, Helsinki, Finland.4 aut |
700 | 1 | a Heervä, Eetuu Turku Univ Hosp, Dept Oncol, Turku, Finland.;Univ Turku, Turku, Finland.4 aut |
700 | 1 | a Lehtomäki, Kaisau Tampere Univ Hosp, Dept Oncol, Teiskontie 35,POB 2000, Tampere 33520, Finland.;Univ Tampere, Tampere, Finland.4 aut |
700 | 1 | a Räsänen, Jariu Univ Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Dept Thorac Surg, Helsinki, Finland.4 aut |
700 | 1 | a Murashev, Maijau Satakunta Cent Hosp, Dept Oncol, Pori, Finland.4 aut |
700 | 1 | a Aroviita, Laurau Kanta Hame Cent Hosp, Dept Oncol, Hameenlinna, Finland.4 aut |
700 | 1 | a Jekunen, Anttiu Vaasa Cent Hosp, Dept Oncol, Vaasa, Finland.4 aut |
700 | 1 | a Lindvall-Andersson, Reneeu Aland Cent Hosp, Dept Oncol, Mariehamn, Finland.4 aut |
700 | 1 | a Nyandoto, Paulu Paijat Name Cent Hosp, Dept Oncol, Lahti, Finland.4 aut |
700 | 1 | a Kononen, Juhau Cent Hosp Cent Finland, Dept Oncol, Jyvaskyla, Finland.4 aut |
700 | 1 | a Lepistö, Annau Univ Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Dept Gastrointestinal Surg, Helsinki, Finland.4 aut |
700 | 1 | a Poussa, Tuijau StatConsulting, Nokia, Finland.4 aut |
700 | 1 | a Muhonen, Timou South Carelia Cent Hosp, Dept Oncol, Lappeenranta, Finland.4 aut |
700 | 1 | a Ålgars, Annikau Turku Univ Hosp, Dept Oncol, Turku, Finland.;Univ Turku, Turku, Finland.4 aut |
700 | 1 | a Isoniemi, Helenau Univ Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Dept Transplantat & Liver Surg, Helsinki, Finland.4 aut |
710 | 2 | a Karolinska Institutetb Tampere Univ Hosp, Dept Oncol, Teiskontie 35,POB 2000, Tampere 33520, Finland.;Univ Tampere, Tampere, Finland.;Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland.;Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Karolinska Univ Hosp, Stockholm, Sweden.4 org |
773 | 0 | t The Lancet Regional Healthd : Elsevierg 3q 3x 2666-7762 |
856 | 4 | u https://doi.org/10.1016/j.lanepe.2021.100049y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1583254/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://doi.org/10.1016/j.lanepe.2021.100049 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-446847 |
856 | 4 8 | u https://doi.org/10.1016/j.lanepe.2021.100049 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:154400671 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy